Related Experiment Video
Updated: Aug 13, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Antibodies against the paramyxovirus SV5 are not specific for cerebrospinal fluid from multiple sclerosis patients
1Department of Neurochemistry, Institute of Neurology, London, U.K.
Abstract:
An aetiological agent for multiple sclerosis has not yet been identified. The paramyxovirus SV5 (Simian virus 5) has been suggested as an important cause in some cases. Using antigen immunoblotting with SV5 virus, we confirmed the binding to SV5 of immunoglobulin G from the cerebrospinal fluid of 58% of multiple sclerosis patients, but also found binding in 70% of patients with a variety of neurological disorders where oligoclonal banding was present. This suggests that the antibodies present are not specific for multiple sclerosis and that the SV5 virus is thus unlikely to be of aetiological significance.
Insights
Researchers investigated Simian virus 5 (SV5) as a cause for multiple sclerosis (MS). Antibodies targeting SV5 were found in MS patients, but also in other neurological disorders, suggesting SV5 is unlikely to cause MS.
Area of Science:
- Neuroimmunology
- Virology
- Infectious Diseases
Background:
- The causative agent of multiple sclerosis (MS) remains unknown.
- Paramyxoviruses, including Simian virus 5 (SV5), have been proposed as potential etiological factors in MS.
- Investigating viral links is crucial for understanding MS pathogenesis.
Purpose of the Study:
- To determine if Simian virus 5 (SV5) antibodies in cerebrospinal fluid are specific to multiple sclerosis.
- To assess the etiological significance of SV5 in the development of MS.
Main Methods:
- Antigen immunoblotting was used to detect immunoglobulin G (IgG) antibodies against SV5.
- Cerebrospinal fluid (CSF) samples from multiple sclerosis patients were analyzed.
- CSF samples from patients with other neurological disorders and oligoclonal banding were included for comparison.
Main Results:
- Immunoglobulin G (IgG) antibodies binding to SV5 were detected in 58% of multiple sclerosis patients.
- SV5-binding antibodies were also found in 70% of patients with various neurological disorders exhibiting oligoclonal banding.
- The presence of SV5 antibodies was not specific to multiple sclerosis.
Conclusions:
- The antibodies detected against SV5 in cerebrospinal fluid are not unique to multiple sclerosis patients.
- The findings suggest that SV5 is unlikely to be an etiological agent responsible for causing multiple sclerosis.
- Further research is needed to identify the true causative agents of MS.
Related Concept Videos
Viral Meningitis
Respiratory Syncytial Virus Disease

